Mitoxantrone, prednimustine, and vincristine for elderly patients with aggressive non-Hodgkin's lymphomaJonathan C. Yau, Glenwood Goss, Colin Germond et al.|American Journal of Hematology|1998Cited by 6
Personalized oncology and BRAFK601N melanoma: model development, drug discovery, and clinical correlationBrian A. Keller, John C. Bell, Marie-Ève Wedge et al.|Journal of Cancer Research and Clinical Oncology|2021Cited by 4